Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2322932rdf:typepubmed:Citationlld:pubmed
pubmed-article:2322932lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2322932lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:2322932lifeskim:mentionsumls-concept:C0029925lld:lifeskim
pubmed-article:2322932lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:2322932lifeskim:mentionsumls-concept:C1521761lld:lifeskim
pubmed-article:2322932lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:2322932lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:2322932pubmed:issue3lld:pubmed
pubmed-article:2322932pubmed:dateCreated1990-5-11lld:pubmed
pubmed-article:2322932pubmed:abstractTextClonogenic growth (defined as the formation of greater than or equal to 5 colonies per 5 x 10(5) viable nucleated cells per plate) of ovarian cancer specimens assessed in our clonogenic assay system was significantly associated with the proportion of tumor cells in the suspensions plated (N = 87; P = 0.0006), although there was no quantitative relationship with the corresponding plating efficiencies. An inverse correlation was observed between monocytes/macrophages/mesothelial cells (M) proportion and clonogenic growth (P = 0.013). These associations were most evident when only effusions were considered. Univariate analyses identified tumor cell content, M proportion and, to a lesser degree, granulocyte content as the only factors out of 12 examined to be correlated with colony formation. Multivariate analysis using a logistic regression model identified the proportion of tumor cells as the only significant factor predicting clonogenic growth in vitro (P = 0.0006). The overall accuracy of prediction for growth or non-growth was 63.2%.lld:pubmed
pubmed-article:2322932pubmed:languageenglld:pubmed
pubmed-article:2322932pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2322932pubmed:citationSubsetIMlld:pubmed
pubmed-article:2322932pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2322932pubmed:statusMEDLINElld:pubmed
pubmed-article:2322932pubmed:monthAprlld:pubmed
pubmed-article:2322932pubmed:issn0304-3835lld:pubmed
pubmed-article:2322932pubmed:authorpubmed-author:SalzerHHlld:pubmed
pubmed-article:2322932pubmed:authorpubmed-author:HudecMMlld:pubmed
pubmed-article:2322932pubmed:authorpubmed-author:DittrichCClld:pubmed
pubmed-article:2322932pubmed:authorpubmed-author:SeveldaPPlld:pubmed
pubmed-article:2322932pubmed:authorpubmed-author:WrbaFFlld:pubmed
pubmed-article:2322932pubmed:authorpubmed-author:DittrichEElld:pubmed
pubmed-article:2322932pubmed:authorpubmed-author:EliasonJJlld:pubmed
pubmed-article:2322932pubmed:authorpubmed-author:GruntTTlld:pubmed
pubmed-article:2322932pubmed:issnTypePrintlld:pubmed
pubmed-article:2322932pubmed:day30lld:pubmed
pubmed-article:2322932pubmed:volume50lld:pubmed
pubmed-article:2322932pubmed:ownerNLMlld:pubmed
pubmed-article:2322932pubmed:authorsCompleteYlld:pubmed
pubmed-article:2322932pubmed:pagination183-9lld:pubmed
pubmed-article:2322932pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:2322932pubmed:meshHeadingpubmed-meshheading:2322932-...lld:pubmed
pubmed-article:2322932pubmed:meshHeadingpubmed-meshheading:2322932-...lld:pubmed
pubmed-article:2322932pubmed:meshHeadingpubmed-meshheading:2322932-...lld:pubmed
pubmed-article:2322932pubmed:meshHeadingpubmed-meshheading:2322932-...lld:pubmed
pubmed-article:2322932pubmed:meshHeadingpubmed-meshheading:2322932-...lld:pubmed
pubmed-article:2322932pubmed:meshHeadingpubmed-meshheading:2322932-...lld:pubmed
pubmed-article:2322932pubmed:meshHeadingpubmed-meshheading:2322932-...lld:pubmed
pubmed-article:2322932pubmed:meshHeadingpubmed-meshheading:2322932-...lld:pubmed
pubmed-article:2322932pubmed:meshHeadingpubmed-meshheading:2322932-...lld:pubmed
pubmed-article:2322932pubmed:meshHeadingpubmed-meshheading:2322932-...lld:pubmed
pubmed-article:2322932pubmed:meshHeadingpubmed-meshheading:2322932-...lld:pubmed
pubmed-article:2322932pubmed:meshHeadingpubmed-meshheading:2322932-...lld:pubmed
pubmed-article:2322932pubmed:meshHeadingpubmed-meshheading:2322932-...lld:pubmed
pubmed-article:2322932pubmed:meshHeadingpubmed-meshheading:2322932-...lld:pubmed
pubmed-article:2322932pubmed:year1990lld:pubmed
pubmed-article:2322932pubmed:articleTitleAnalysis of factors influencing clonogenic growth in vitro of cells from ovarian carcinoma patients.lld:pubmed
pubmed-article:2322932pubmed:affiliationDepartment of Chemotherapy, University of Vienna, Austria.lld:pubmed
pubmed-article:2322932pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2322932pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:2322932pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed